Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Cameli

Showing results (381-390 of 399) with videos related to

Pageof 40
Sort By:
European Heart Journal Open|August 3, 2022
Sacubitril/valsartan reduces indications for arrhythmic primary prevention in heart failure with reduced ejection fraction: insights from DISCOVER-ARNI, a multicenter Italian registerMaria Concetta Pastore, Giulia Elena Mandoli, Alberto Giannoni, et al.
Journal of Clinical Medicine|December 24, 2021
Biomarkers Predict In-Hospital Major Adverse Cardiac Events in COVID-19 Patients: A Multicenter International StudyMichael Y Henein, Giulia Elena Mandoli, Maria Concetta Pastore, et al.
American Heart Journal|June 5, 2024
Echocardiographic and clinical features of patients developing prosthesis-patient mismatch after transcatheter aortic valve replacement: Insights from the Recovery-TAVR registryFrancesco Bruno, Joao Matteo Rampone, Fabian Islas, et al.
European Journal of Heart Failure|June 26, 2024
OPTImal PHARMacological therapy for patients with heart failure: Rationale and design of the OPTIPHARM-HF registryRiccardo M Inciardi, Muthiah Vaduganathan, Carlo M Lombardi, et al.
European Journal of Preventive Cardiology|September 9, 2021
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization - the first insight from the AC-TIVE StudyMarco Merlo, Aldostefano Porcari, Linda Pagura, et al.
La Radiologia Medica|September 23, 2025
SIRM/SIC consensus document on the management of patients with acute chest painAntonio Esposito, Riccardo Faletti, Anna Palmisano, et al.
European Journal of Heart Failure|April 13, 2022
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC-TIVE study, an Italian nationwide surveyMarco Merlo, Linda Pagura, Aldostefano Porcari, et al.
ESC Heart Failure|September 20, 2024
Early diagnosis, disease stage and prognosis in wild-type transthyretin amyloid cardiomyopathy: The DIAMOND studyGiacomo Tini, Beatrice Musumeci, Paolo Milani, et al.
European Journal of Heart Failure|March 12, 2023
Diagnostic pathways to wild-type transthyretin amyloid cardiomyopathy: a multicentre network studyGiacomo Tini, Paolo Milani, Mattia Zampieri, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|February 17, 2026
Acute coronary syndrome and coronary artery disease in wild-type transthyretin amyloid cardiomyopathy: a DIAMOND sub-studyLaura De Michieli, Giacomo Tini, Alessia Argirò, et al.
Pageof 40

Showing results (381-390 of 399) with videos related to

Sort By:
Pageof 40
European Heart Journal Open|August 3, 2022
Sacubitril/valsartan reduces indications for arrhythmic primary prevention in heart failure with reduced ejection fraction: insights from DISCOVER-ARNI, a multicenter Italian registerMaria Concetta Pastore, Giulia Elena Mandoli, Alberto Giannoni, et al.
Journal of Clinical Medicine|December 24, 2021
Biomarkers Predict In-Hospital Major Adverse Cardiac Events in COVID-19 Patients: A Multicenter International StudyMichael Y Henein, Giulia Elena Mandoli, Maria Concetta Pastore, et al.
American Heart Journal|June 5, 2024
Echocardiographic and clinical features of patients developing prosthesis-patient mismatch after transcatheter aortic valve replacement: Insights from the Recovery-TAVR registryFrancesco Bruno, Joao Matteo Rampone, Fabian Islas, et al.
European Journal of Heart Failure|June 26, 2024
OPTImal PHARMacological therapy for patients with heart failure: Rationale and design of the OPTIPHARM-HF registryRiccardo M Inciardi, Muthiah Vaduganathan, Carlo M Lombardi, et al.
European Journal of Preventive Cardiology|September 9, 2021
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization - the first insight from the AC-TIVE StudyMarco Merlo, Aldostefano Porcari, Linda Pagura, et al.
La Radiologia Medica|September 23, 2025
SIRM/SIC consensus document on the management of patients with acute chest painAntonio Esposito, Riccardo Faletti, Anna Palmisano, et al.
European Journal of Heart Failure|April 13, 2022
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC-TIVE study, an Italian nationwide surveyMarco Merlo, Linda Pagura, Aldostefano Porcari, et al.
ESC Heart Failure|September 20, 2024
Early diagnosis, disease stage and prognosis in wild-type transthyretin amyloid cardiomyopathy: The DIAMOND studyGiacomo Tini, Beatrice Musumeci, Paolo Milani, et al.
European Journal of Heart Failure|March 12, 2023
Diagnostic pathways to wild-type transthyretin amyloid cardiomyopathy: a multicentre network studyGiacomo Tini, Paolo Milani, Mattia Zampieri, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|February 17, 2026
Acute coronary syndrome and coronary artery disease in wild-type transthyretin amyloid cardiomyopathy: a DIAMOND sub-studyLaura De Michieli, Giacomo Tini, Alessia Argirò, et al.
Pageof 40